Application Nr Approved Date Route Status External Links
ANDA088481 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Allergic States Control Of Severe Or Incapacitating Allergic Conditions Intractable To Adequate Trials Of Conventional Treatment In Asthma, Atopic Dermatitis, Contact Dermatitis, Drug Hypersensitivity Reactions, Seasonal Or Perennial Allergic Rhinitis And Serum Sickness. Dermatologic Diseases Bullous Dermatitis Herpetiformis, Exfoliative Erythroderma, Mycosis Fungoides, Pemphigus, And Severe Erythema Multiforme (stevens-Johnson Syndrome). Endocrine Disorders Primary Or Secondary Adrenocortical Insufficiency (hydrocortisone Or Cortisone Is The First Choice; May Be Used In Conjunction With Synthetic Mineralocorticoid Analogs Where Applicable; In Infancy Mineralocorticoid Supplementation Is Of Particular Importance), Congenital Adrenal Hyperplasia, Hypercalcemia Associated With Cancer, And Nonsuppurative Thyroiditis. Gastrointestinal Diseases To Tide The Patient Over A Critical Period Of The Disease In Regional Enteritis And Ulcerative Colitis. Hematologic Disorders Acquired (autoimmune) Hemolytic Anemia, Congenital (erythroid) Hypoplastic Anemia (diamond-Blackfan Anemia), Idiopathic Thrombocytopenic Purpura In Adults, Pure Red Cell Aplasia, And Selected Cases Of Secondary Thrombocytopenia. Miscellaneous Diagnostic Testing Of Adrenocortical Hyperfunction, Trichinosis With Neurologic Or Myocardial Involvement, Tuberculous Meningitis With Subarachnoid Block Or Impending Block When Used With Appropriate Antituberculous Chemotherapy. Neoplastic Diseases For Palliative Management Of Leukemias And Lymphomas. Nervous System Acute Exacerbations Of Multiple Sclerosis, Cerebral Edema Associated With Primary Or Metastatic Brain Tumor, Craniotomy, Or Head Injury. Ophthalmic Diseases Sympathetic Ophthalmia, Temporal Arteritis, Uveitis, And Ocular Inflammatory Conditions Unresponsive To Topical Corticosteroids. Renal Diseases To Induce A Diuresis Or Remission Of Proteinuria In Idiopathic Nephrotic Syndrome Or That Due To Lupus Erythematosus. Respiratory Diseases Berylliosis, Fulminating Or Disseminated Pulmonary Tuberculosis When Used Concurrently With Appropriate Antituberculous Chemotherapy, Idiopathic Eosinophilic Pneumonias, Symptomatic Sarcoidosis. Rheumatic Disorders As Adjunctive Therapy For Short-Term Administration (to Tide The Patient Over An Acute Episode Or Exacerbation) In Acute Gouty Arthritis, Acute Rheumatic Carditis, Ankylosing Spondylitis, Psoriatic Arthritis, Rheumatoid Arthritis, Including Juvenile Rheumatoid Arthritis (selected Cases May Require Low-Dose Maintenance Therapy). For The Treatment Of Dermatomyositis, Polymyositis, And Systemic Lupus Erythematosus.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dexamethasone DEXAMETHASONE ZINC4654654

Comments